期刊文献+

子痫前期患者血清IGF-1、PLGF、sFlt-1、sCD40L水平与围生结局的关系研究 被引量:2

Relationship between serum insulin-like growth factor-1,placental growth factor,soluble vascular endothelial growth factor receptor-1,soluble CD40L ligand levels and perinatal outcome in patients with preeclampsia
下载PDF
导出
摘要 目的探讨子痫前期患者血清胰岛素样生长因子-1(IGF-1)、胎盘生长因子(PLGF)、可溶性血管内皮生长因子受体-1(sFlt-1)、可溶性CD40L配体(sCD40L)水平与围生结局的关系。方法选择2020年9月至2022年2月陕西中医药大学第二附属医院收治的96例子痫前期患者作为观察组,并选择同期我院产检的健康孕妇96例作为对照组。比较观察组和对照组、观察组不同病情程度患者的血清IGF-1、PLGF、sFlt-1、sCD40L水平,并比较观察组和对照组的不良围生结局发生率以及观察组不同围生结局患者的血清IGF-1、PLGF、sFlt-1、sCD40L水平,采用Pearson相关性分析法分析血清IGF-1、PLGF、sFlt-1、sCD40L水平和不良围生结局的相关性。结果观察组患者的血清IGF-1、PLGF水平分别为(80.03±16.72)μg/L、(137.25±26.80)pg/mL,明显低于对照组的(222.01±32.64)μg/L、(312.57±41.23)pg/mL,sFlt-1、sCD40L水平分别为(1451.83±205.27)ng/L、(8.11±1.64)ng/L,明显高于对照组的(309.83±51.71)ng/L、(2.87±0.49)ng/L,差异均有统计学意义(P<0.05);观察组中病情重度组患者的血清IGF-1、PLGF水平分别为(68.92±7.68)μg/L、(101.52±16.32)pg/mL,明显低于轻度组的(102.83±11.57)μg/L、(158.27±21.60)pg/mL,sFlt-1、sCD40L水平分别为(1178.54±158.91)ng/L、(6.40±1.21)ng/L,明显高于轻度组的(1670.32±173.66)ng/L、(9.97±1.59)ng/L,差异均有统计学意义(P<0.05);观察组患者的不良围生结局总发生率为23.96%,明显高于对照组的4.17%,差异有统计学意义(P<0.05);观察组中结局不良组患者的血清IGF-1、PLGF水平分别为(65.12±7.59)μg/L、(104.29±18.73)pg/mL,明显低于结局良好组的(98.80±13.26)μg/L、(155.61±21.49)pg/mL,sFlt-1、sCD40L水平分别为(1038.67±171.40)ng/L、(6.19±1.52)ng/L,明显高于结局良好组的(1693.82±213.25)ng/L、(10.01±1.71)ng/L,差异均有统计学意义(P<0.05);经Pearson相关性分析结果显示,血清IGF-1、PLGF和不良围生结局之间呈负相关(r=-0.527、-0.585,P<0.05),血清sFlt-1、sCD40L和不良围生结局之间呈正相关(r=0.493、0.526,P<0.05)。结论子痫前期患者血清IGF-1、PLGF水平明显降低,血清sFlt-1、sCD40L水平明显升高,且和不良围生结局具有明显相关性。 Objective To study the relationship between serum insulin-like growth factor-1(IGF-1),placental growth factor(PLGF),soluble vascular endothelial growth factor receptor-1(sFlt-1),soluble CD40L ligand(sCD40L)levels and perinatal outcomes in patients with preeclampsia.Methods A total of 96 patients with preeclampsia admitted to the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine from September 2020 to February 2022 were selected as the observation group,and 96 healthy pregnant women who underwent prenatal examination in the hospital during the same period were selected as the control group.The serum IGF-1,PLGF,sFlt-1 and sCD40L levels were compared between the observation group and the control group,and between the observation group with different degrees of illness.The incidence of adverse perinatal outcomes in the observation group and the control group,and the serum IGF-1,PLGF,sFlt-1 and sCD40L levels in the observation group with different perinatal outcomes were compared.Pearson correlation analysis was used to analyze the correlation between the serum IGF-1,PLGF,sFlt-1,sCD40L levels and adverse perinatal outcomes.Results The serum IGF-1,PLGF levels in the observation group were(80.03±16.72)μg/L and(137.25±26.80)pg/mL,which were significantly lower than(222.01±32.64)μg/L and(312.57±41.23)pg/mL in the control group,and the sFlt-1 and sCD40L levels were(1451.83±205.27)ng/L and(8.11±1.64)ng/L,significantly higher than(309.83±51.71)ng/L and(2.87±0.49)ng/L in the control group(P<0.05).The serum IGF-1,PLGF levels in the severe group of the observation group were(68.92±7.68)μg/L and(101.52±16.32)pg/mL,which were significantly lower than(102.83±11.57)μg/L and(158.27±21.60)pg/mL in the mild group,while the sFlt-1 and sCD40L levels were(1178.54±158.91)ng/L and(6.40±1.21)ng/L,significantly higher than(1670.32±173.66)ng/L and(9.97±1.59)ng/L in the mild group(P<0.05).The total incidence of adverse perinatal outcomes in the observation group was 23.96%,which was significantly higher than 4.17%in the control group(P<0.05).The IGF-1 and PLGF levels in the poor outcome group of the observation group were(65.12±7.59)μg/L and(104.29±18.73)pg/mL,which were significantly lower than(98.80±13.26)μg/L and(155.61±21.49)pg/mL in the good outcome group,while the sFlt-1 and sCD40L levels were(1038.67±171.40)ng/L and(6.19±1.52)ng/L,significantly higher than(1693.82±213.25)ng/L and(10.01±1.71)ng/L in the good outcome group,(P<0.05).Pearson correlation analysis results showed that serum IGF-1 and PLGF were negatively correlated with adverse perinatal outcomes(r=-0.527,-0.585,P<0.05),while serum sFlt-1 and sCD40L were positively correlated with adverse perinatal outcomes(r=0.493,0.526,P<0.05).Conclusion The levels of serum IGF-1 and PLGF in patients with preeclampsia were significantly decreased,and the levels of serum sFlt-1 and sCD40L were significantly increased,which were significantly correlated with adverse perinatal outcomes.
作者 连李斌 陈蓓 段蓓 LIAN Li-bin;CHEN Bei;DUAN Bei(Department of Obstetrics and Gynecology,the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Xianyang 712000,Shaanxi,CHINA)
出处 《海南医学》 CAS 2023年第7期983-986,共4页 Hainan Medical Journal
基金 陕西省卫生健康科研基金项目(编号:2018D085)。
关键词 子痫前期 胰岛素样生长因子-1 胎盘生长因子 可溶性血管内皮生长因子受体-1 可溶性CD40L配体 围生结局 相关性 Preeclampsia Insulin like growth factor-1 Placental growth factor Soluble vascular endothelial growth factor receptor-1 Soluble CD40L ligand Perinatal outcome Correlation
  • 相关文献

参考文献9

二级参考文献107

  • 1黄峻,鞠文东,熊小英,陈昂,吴礼凤.子痫前期孕妇血压昼夜节律异常与围生儿结局的关系分析[J].江苏实用心电学杂志,2013,22(2):576-579. 被引量:8
  • 2American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy.Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5):1122-1131.
  • 3Magee LA, Pels A, Helewa M, et al.Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary[J]. J Obstet Gynaecol Can, 2014, 36(5):416-441.
  • 4Visintin C, Mugglestone MA, Almerie MQ, et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance[J]. BMJ, 2010, 341 :c2207.
  • 5Lowe SA, Bowyer L, Lust K, et al. The SOMANZ Guidelines for the Management of Hypertensive Disorders of Pregnancy 2014[J]. Aust N Z J Obstet Gynaecol, 2015, 55(1):11-16.
  • 6Campos-Outcah D Sr. US Preventive Services Task Force: the gold standard of evidence-based prevention[J]. J Fam Pract, 2005, 54(6):517-519.
  • 7Magee LA, Hdewa M, Momquin JM, et al. Diagnosis, evaluation,and management of the hypertensive disorders of pregnancy[J]. J Obstet Gynaeeol Can, 2008, 30 (Suppl): S1-48.
  • 8Cote AM, Brown MA, Laln E, et al. Diagnostic accuracy of urinary spot protein: creatiniue ratio for proteinuria in hypertensive pregnant women: systematic review[J]. BMJ, 2008, 336(7651): 1003-1006.
  • 9Churchill D, Beevers GD, Meher S, et al, Diuretics for preventing pre-eclampsia[J]. Cochrane Database Syst Rev, 2007, 24 (1):CD004451.
  • 10McCoy S, Baldwin K. Pharmacotherapeutie options for the treatment of preeelampsia[J]. Am J Health Syst Pharm, 2009, 66(4):337-344.

共引文献1289

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部